Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Structure Based Design is a private San Diego-based biotech and contract research company focused on structure-based drug discovery services for pharmaceutical, biotechnology, and academic clients. The company specializes in recombinant protein production, protein structure determination, macromolecule X-ray crystallography, fragment-based crystallographic screening, assay development, and gene-to-lead discovery support. Its business model appears to center on enabling client programs rather than advancing a large disclosed proprietary therapeutic pipeline. Structure Based Design also highlights capabilities in kinase, GPCR, and antibody discovery and has supported discovery programs such as tomivosertib through structural biology and crystallography. The company presents itself as an embedded scientific partner intended to accelerate hit identification and lead optimization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Structure Based Design.